Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes

NCT06545461 is registered in ClinicalTrials.gov with Donald Wesson as lead sponsor.

NCT NCT06545461
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06545461 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Metabolic Acidosis in Chronic Kidney Disease to Prevent Adverse Kidney and Cardiovascular Outcomes
Lead sponsor
Donald Wesson
Phase
Not applicable
Overall status
Completed
Start date
June 22, 1998
Completion date
October 30, 2016
Enrollment
108 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, chronic kidney diseases, hypertension